Chronic Leukemia Rounds
- Educational Objectives
- Accreditation Info.
- San Francisco
About the Chronic Leukemia Rounds
The CLRounds will provide a forum to discuss and to share best practices of diagnosis and treatment issues, including new therapies, clinical trials, side-effect management, treatment adherence, and other issues related to managing patients with Chronic Lymphocytic Leukemia (CLL) or Chronic Myeloid Leukemia (CML).
Through interactive case study discussions, the CLRounds will provide an opportunity for healthcare providers to exchange information, network with colleagues, share best practices and learn about new therapies and advances in the management of chronic leukemias.
At the conclusion of this program, participants will be able to:
• Describe the latest clincal data on prognostic indicators that can be used to inform a specific treatment plan for patients with CLL or CML
• Identify criteria for response assessment and molecular monitoring in the treatment of chronic leukemias
• Consider emerging clinical data on novel agents and emerging therapeutic strategies that have the potential to improve the outcomes for patients with chronic leukemia
• Address potential barriers to treatment adherence for chronic leukemias
Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity provides 2.0 ONCC credit hours. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses.
This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
There is no fee to participate in this activity.
This program is supported by educational grants received from AbbVie and Janssen Biotech, Inc.
Boston, MA - Thursday, November 7, 2019 6:00 - 8:30 pm
Boston Marriott Copley Place, 110 Huntington Avenue, Boston
Boston CLRounds Co-Chairs
Jon E. Arnason, MD
Beth Israel Deaconess Medical Center, Boston, MA
Anita Kumar, MD, MS
Tufts Medical Center, Boston, MA
Jointly provided by The Leukemia & Lymphoma Society, PleXus Communications, and Rush University.
If your company is interested in exhibiting at any of these events, please contact us at:
Email: [email protected]